Effect of Honey and Cinnamon mixture on improving patient's quality of life
Phase 3
Completed
- Conditions
- Breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT201409081772N16
- Lead Sponsor
- Vice Chancellor for Research, Faculty of Medicine,Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
inclusion criteria: patients in rang of 20-60 Y/O; life expectancy more than 6 month; willingness to participation in the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Life. Timepoint: ?At first and at the seventh day of the study. Method of measurement: EORTC QLQ-C30 questionnaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie honey and cinnamon's anti-inflammatory effects in breast cancer patients?
How does IRCT201409081772N16 compare to standard-of-care adjuvants like tamoxifen or aromatase inhibitors in ER+/HER2- breast cancer?
Are there specific biomarkers (e.g., ER/PR/HER2 status) that predict response to honey-cinnamon mix in metastatic breast cancer?
What adverse events are associated with long-term honey-cinnamon consumption in breast cancer patients undergoing chemotherapy?
What evidence supports combining honey-cinnamon with immunotherapy (e.g., PD-1 inhibitors) for triple-negative breast cancer?